Introduction to Kimberly-Clark and Kenvue
Kimberly-Clark, a well-known company based in Irving, Texas, has announced a major deal to acquire Kenvue, a consumer health care company, for nearly $50 billion. This acquisition is expected to take place in the second half of 2026, pending regulatory approval. Kimberly-Clark is one of the largest companies in the Dallas-Fort Worth area and is behind recognizable brands such as Kleenex, Cottonelle, and Huggies. The company also produces specialized products for use in sensitive environments like laboratories.
When Kenvue joins Kimberly-Clark, it will bring even more household names under one roof. Kenvue is a significant player in the consumer health care industry, and its products are sold in nearly every country. The company has over 20,000 employees globally and generated $15.5 billion in revenue in 2024.
What does Kenvue make?
Kenvue owns a range of well-known brands, including Aveeno, Band-Aid, Benadryl, Clean & Clear, Johnson’s Baby, Listerine, Lubriderm, Motrin, Neosporin, Neutrogena, Nicorette, Pepcid, Rogaine, Sudafed, Tylenol, Visine, and Zyrtec. The company also produces a variety of other consumer health products.
- Aveeno
- Band-Aid
- Benadryl
- Clean & Clear
- Johnson’s Baby
- Listerine
- Lubriderm
- Motrin
- Neosporin
- Neutrogena
- Nicorette
- Pepcid
- Rogaine
- Sudafed
- Tylenol
- Visine
- Zyrtec
What is Kenvue?
Kenvue was originally the consumer health care division of pharmaceutical and biotech giant Johnson & Johnson. In 2021, Johnson & Johnson announced that it would spin off the division as its own company to focus on the more lucrative pharmaceutical and medical device sectors. The new separate company, Kenvue, did an initial public offering of stock in 2023, with a total market capitalization of $41 billion.
Business Briefing: Become a business insider with the latest news. By signing up, you agree to our Terms of Service and Privacy Policy.
Where is Kenvue based?
Kenvue was headquartered in Skillman, New Jersey, near its former parent company Johnson & Johnson’s New Brunswick headquarters. The company has been slowly relocating its headquarters to Summit, New Jersey, which puts it closer to New York City. Kenvue will still maintain a “significant presence” in its New Jersey offices following its acquisition by Kimberly-Clark, according to the announcement.
How has Kenvue dealt with the Trump administration’s stance on Tylenol?
Recently, President Donald Trump and his administration linked the use of acetaminophen, including Tylenol, during pregnancy to growing rates of autism. Trump, alongside health secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services, made the announcement in September. The U.S. Food and Drug Administration began the process of changing the safety label for acetaminophen products.
Texas Attorney General Ken Paxton joined in last week, suing Kenvue for allegedly hiding autism risks. Throughout this controversy, Kenvue has maintained that Tylenol is safe when used as directed, and said that Paxton’s suit “lack[s] legal merit and scientific support.”
Medical professionals and groups largely agree on the safety of Tylenol, especially when used under a doctor’s supervision, and research has not shown that Tylenol or other acetaminophen products cause autism. In September, the American College of Obstetricians and Gynecologists posted on social media that acetaminophen is a “safe, trusted option for pain relief during pregnancy.” Fevers, which Tylenol can be used for, pose harm to pregnant women and their babies when left untreated.
Entering its second year, judges are trying to push the new business-centric system ahead of Delaware.
The affected positions are primarily at the carrier’s Fort Worth HQ.
